DE602006014186D1 - Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzung - Google Patents
Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzungInfo
- Publication number
- DE602006014186D1 DE602006014186D1 DE602006014186T DE602006014186T DE602006014186D1 DE 602006014186 D1 DE602006014186 D1 DE 602006014186D1 DE 602006014186 T DE602006014186 T DE 602006014186T DE 602006014186 T DE602006014186 T DE 602006014186T DE 602006014186 D1 DE602006014186 D1 DE 602006014186D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide
- gsmtx4
- producing
- recombinant
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 230000000202 analgesic effect Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009987 spinning Methods 0.000 title 1
- 101000623875 Grammostola rosea M-theraphotoxin-Gr1a Proteins 0.000 abstract 4
- WVDNTWXIIKNMHY-UHFFFAOYSA-N GsMTx4 Chemical compound O=C1NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCCCN)C(=O)NC(C(NC(CC(N)=O)C(=O)N2CCCC2C(=O)NC(CC(N)=O)C(=O)NC(CC(O)=O)C(=O)NC(CC(O)=O)C(=O)NC(CCCCN)C(=O)NC(CSSCC(NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC=2C=CC=CC=2)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CO)C(=O)NC(CC=3C=CC=CC=3)C(N)=O)C(=O)N3)=O)CSSCC2NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C3CSSCC(NC(=O)CN)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC1CC1=CC=CC=C1 WVDNTWXIIKNMHY-UHFFFAOYSA-N 0.000 abstract 4
- 108010025188 Alcohol oxidase Proteins 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 102000004310 Ion Channels Human genes 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000002708 spider venom Substances 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Insects & Arthropods (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050098082A KR100761790B1 (ko) | 2005-10-18 | 2005-10-18 | ＧｓＭＴｘ4 유전자를 포함하는 효모 발현용 재조합플라스미드 및 이를 이용한 칠레산 타란툴라 거미독펩타이드 ＧｓＭＴｘ4의 생산 방법 |
| KR1020060001918A KR100761792B1 (ko) | 2006-01-06 | 2006-01-06 | ＧｓＭＴｘ4 펩타이드 및 그 유도체를 유효성분으로함유하는 통증치료용 조성물 |
| PCT/KR2006/004242 WO2007046634A1 (en) | 2005-10-18 | 2006-10-18 | Method for preparing recombinant peptide from spider venom and analgesic composition containing the peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006014186D1 true DE602006014186D1 (de) | 2010-06-17 |
Family
ID=37962693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006014186T Active DE602006014186D1 (de) | 2005-10-18 | 2006-10-18 | Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzung |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20090023183A1 (de) |
| EP (1) | EP1948679B1 (de) |
| AT (1) | ATE466873T1 (de) |
| DE (1) | DE602006014186D1 (de) |
| WO (1) | WO2007046634A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0605484A8 (pt) * | 2006-11-21 | 2017-03-07 | Fund Amparo Pesquisa Estado Minas Gerais Fapemig | Toxina ph(alfa)1b, cdna do gene da toxina ph(alfa)1b, composições farmacêuticas contendo a toxina ph(alfa)1b, processo para sua obtenção, processo para obtenção do cdna, e produto |
| JP2016500836A (ja) | 2012-10-04 | 2016-01-14 | ナノコ テクノロジーズ リミテッド | 量子ドットを用いた電飾看板 |
| US9551718B2 (en) | 2014-06-20 | 2017-01-24 | The Royal Institution For The Advancement Of Learning/Mcgill University | TMEM120A ion channel modulator |
| WO2017068388A2 (pt) * | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
| CN106632603B (zh) * | 2016-12-09 | 2019-05-17 | 唐琼瑶 | 一组肽及其药物组合物和应用 |
| SG11201909017XA (en) | 2017-04-04 | 2019-10-30 | Univ Baylor | Targeted mosquitocidal toxins |
| CN113214376B (zh) * | 2021-03-30 | 2023-09-19 | 青岛大学 | 一种新的合成蜈蚣毒素RhTx和蜘蛛毒素GsMTx4的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2221788C2 (ru) * | 1991-08-14 | 2004-01-20 | Проктер энд Гэмбл Фармасьютикалз | Оксоциклические соединения мочевины, фармацевтическая композиция, способ лечения |
| KR0127776B1 (ko) * | 1994-10-11 | 1997-12-29 | 허영섭 | 신규한 단백질 분해효소의 cDNA 서열 및 그로 부터 유래된 단백질 |
| US5756663A (en) * | 1996-01-03 | 1998-05-26 | Zeneca Limited | Antiarrhythmic peptide from venom of spider Grammostola spatulata |
| US7125847B1 (en) * | 2000-04-07 | 2006-10-24 | The Research Foundation Of State University Of New York At Buffalo | Mechanically activated channel blocker |
-
2006
- 2006-10-18 EP EP06799316A patent/EP1948679B1/de not_active Not-in-force
- 2006-10-18 US US12/090,664 patent/US20090023183A1/en not_active Abandoned
- 2006-10-18 WO PCT/KR2006/004242 patent/WO2007046634A1/en active Application Filing
- 2006-10-18 AT AT06799316T patent/ATE466873T1/de not_active IP Right Cessation
- 2006-10-18 DE DE602006014186T patent/DE602006014186D1/de active Active
-
2010
- 2010-10-19 US US12/907,475 patent/US20120015886A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE466873T1 (de) | 2010-05-15 |
| EP1948679A4 (de) | 2009-06-17 |
| US20120015886A1 (en) | 2012-01-19 |
| EP1948679B1 (de) | 2010-05-05 |
| EP1948679A1 (de) | 2008-07-30 |
| WO2007046634A1 (en) | 2007-04-26 |
| US20090023183A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006014186D1 (de) | Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzung | |
| ES2623147T3 (es) | Secuencias polipeptídicas inductoras de cuerpos proteicos | |
| Florack et al. | Thionins: properties, possible biological roles and mechanisms of action | |
| BRPI0412125A (pt) | molécula de ácido nucleico isolada, polipeptìdeo de fusão, vetor de expressão, método de produzir um polipeptìdeo de fusão de vegf, captador de fator de crescimento de célula endotelial vascular, composição farmacêutica, método de tratar uma doença ou condição que são restabelecidas, melhoradas ou inibidas pela remoção ou inibição do fator de crescimento endotelial vascular, e, artigo de fabricação | |
| NO20082716L (no) | Sammensetninger og fremgangsmater for fremstilling av en sammensetning | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| Meyer-Ingold et al. | Platelet-derived growth factor. | |
| SI2542257T1 (en) | Optimized monoclonal antibodies against Tissue Factor Pathway Inhibitor (TFPI) | |
| ATE510005T1 (de) | Verfahren zur isolierung von zellen aus der nabelschnur | |
| RU2014141514A (ru) | Терапевтическое дозирование нейрегулина или его подпоследовательности для лечения или профилактики сердечной недостаточности | |
| US11168126B2 (en) | Recombinant elastin and production thereof | |
| DE602004001727D1 (de) | Verfahren zur herstellung cyclischer peptide | |
| Nyström et al. | Therapies for genetic extracellular matrix diseases of the skin | |
| MX341317B (es) | Proteinas de elastasa recombinantes y metodos de fabricacion y uso de las mismas. | |
| CN103757026A (zh) | FGFR2b胞外段的基因序列、多肽及其应用 | |
| UA122856C2 (uk) | Варіантний інсектицидний ген ахмі115 та способи його застосування | |
| EP3257520B1 (de) | Ostreolysin zur verwendung bei der behandlung des steatohepatitis | |
| MX2022011805A (es) | Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con factor ix. | |
| Loo et al. | Hyperstable EGF-like bleogen derived from cactus accelerates corneal healing in rats | |
| JP2020005649A (ja) | 組織線維化の予防又は治療用の組換えタンパク質及びこれを含む組織線維化の予防又は治療用の組成物 | |
| WO2020186207A8 (en) | Non-viral dna vectors and uses thereof for expressing fviii therapeutics | |
| CN105848720A (zh) | 用于诱导葡萄糖摄取的方法 | |
| Jiang et al. | High-level expression and production of human lactoferrin in ${Pichia~ pastoris} $ | |
| Xu et al. | Enhancement of recombinant human interleukin-22 production by fusing with human serum albumin and supplementing N-acetylcysteine in Pichia Pastoris | |
| CN114096556A (zh) | 表皮生长因子受体(egfr)配体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |